Myopia Control With the Multi-segment Lens

The Hong Kong Polytechnic University

Status

Completed

Conditions

Myopia

Treatments

Device: Multiple-Segment spectacle lens

Study type

Interventional

Funder types

Other

Identifiers

NCT02206217

H-ZG3B

Details and patient eligibility

About

The purpose of this study is to determine if the Multiple-Segment (MS) spectacle lens can slow myopia progression in Hong Kong schoolchildren.

MS lens is also called Defocus Incorporated Multiple Segments (DIMS) spectacle lens

Full description

MS lens is a novel lens designed in attempt to slow myopia progression. It is a multifocal spectacle lens which corrects distance refractive error and at the same time produces myopic defocus images on the retina for all distances. The myopic defocus aims at slowing down myopia progression. The purpose of this study is to investigate if the MS lens can slow myopia progression in Hong Kong Chinese schoolchildren. The subjects will be randomly assigned to either treatment group (wear MS lenses) or control group (wear ordinary single vision lenses). Their cycloplegic refraction and axial length will be monitored every six months over 2 years. The changes in refractive errors and axial length in two groups will be compared.

Enrollment

183 patients

Sex

All

Ages

8 to 13 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Age at enrolment: 8-13 year
Spherical equivalent refractions (SER): -1.00 to -5.00 Dioptres (D)
Astigmatism and anisometropia of 1.50 D or less
Spectacle corrected monocular logMAR visual acuity: 0 or better
Parents' understanding and acceptance of random allocation of grouping

Exclusion criteria

any ocular and systemic abnormalities might affect visual functions or refractive development
prior treatment of myopic control, e.g. drugs, orthokeratology, progressive addition lenses, bifocal lenses, drugs (e.g. atropine), etc.